Related Experiment Video

Updated: May 23, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy

Muzammal Hussain1, Aqeel Javeed, Muhammad Ashraf

  • 1Department of Pharmacology & Toxicology, University of Veterinary and Animal Sciences, Lahore, Pakistan.

Pharmacological Research
|March 28, 2012
PubMed

Insights

Non-steroidal anti-inflammatory drugs (NSAIDs) enhance anti-tumor immunity by modulating immune cells. They also boost the effectiveness of cancer immunotherapies like vaccines and monoclonal antibodies.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Non-steroidal anti-inflammatory drugs (NSAIDs) show promise in cancer chemoprevention.
  • NSAIDs are increasingly recognized for their potential in cancer immunotherapy due to immune-enhancing effects.

Purpose of the Study:

  • To review the role of NSAIDs in modulating anti-tumor immunity.
  • To explore the combination of NSAIDs with various cancer immunotherapeutic strategies.
  • To briefly discuss other anti-inflammatories and selective E-prostanoid (EP) receptor antagonists in cancer immunity.

Main Methods:

  • Review of existing literature on NSAIDs, anti-tumor immunity, and cancer immunotherapy.
  • Analysis of immunomodulatory effects of NSAIDs on immune cells (TAM, DC, NK, T cells).
  • Examination of therapeutic combinations of NSAIDs with cancer vaccines, monoclonal antibodies, and cytokine therapy.

Main Results:

  • NSAIDs modulate key immune cells involved in anti-tumor responses, including tumor-associated macrophages (TAM), dendritic cells (DC), natural killer (NK) cells, T effector cells, and T regulatory cells (Treg).
  • NSAIDs can augment the efficacy of cancer vaccines, tumor-specific monoclonal antibodies, and cytokine-based therapies.
  • Other anti-inflammatories and selective EP receptor antagonists also impact tumor immunity.

Conclusions:

  • NSAIDs possess significant immunomodulatory properties beneficial for anti-tumor immunity.
  • Combining NSAIDs with established immunotherapies offers a promising strategy for enhancing cancer treatment.
  • Further research into NSAIDs and related compounds could lead to novel cancer immunotherapy approaches.

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...